![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Abstracts Accepted for Publication - AB0451 Rivaroxaban versus warfarin as secondary thromboprophylaxis in patients with antiphospholipid syndrome protocol: a randomized, multicentre, open-label, clinical trial
Cortés-Hernández, J, Saez-Comet, L, Perez-Conesa, M, Mestre, A Riera, Castro-Salomo, A, Parra, S, Cuquet-Pedragosa, J, Ortiz-Santamaria, V, Mauri-Plana, M, Suñe, P, Ordi-Ros, JLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.6286
File:
PDF, 66 KB
english